We are live on
!
Find out more
SHI
SV Health Investors Portfolio holdings
AUM
$32.3M
1-Year Est. Return
20.15%
This Fund
S&P 500
This Quarter
Est. Return
+27.22%
1 Year Est. Return
-20.15%
3 Year Est. Return
+97.4%
5 Year Est. Return
+328.26%
10 Year Est. Return
–
AUM
$208M
AUM Growth
+$10.2M
(+5.2%)
Cap. Flow
-$10.8M
Cap. Flow
% of AUM
-5.18%
Top 10 Holdings %
Top 10 Hldgs %
100%
Holding
10
New
–
Increased
–
Reduced
3
Closed
1
Top Buys
No buys this quarter
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
American Well
AMWL
|
+$8.3M |
| 2 |
ATXS
Astria Therapeutics
ATXS
|
+$1.77M |
| 3 |
TECX
Tectonic Therapeutic
TECX
|
+$658K |
| 4 |
MSON
Misonix Inc
MSON
|
+$24.6K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 100% |
Similar funds
SAM
FCOMV
LUGPSI
VCA
PGM
ACM
KCM
KXA
SV Health Investors's Q4 2020 Portfolio in Review
As of Q4 2020, SV Health Investors held 10 positions worth $208M, up 5.2% from $197M the previous quarter. Its ten largest holdings account for 100% of the portfolio.
SV Health Investors withdrew a net $10.8M in Q4 2020, closing 1 position and reducing 3 holdings. Its most notable exit was Astria Therapeutics, an estimated $1.77M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 100% of assets, unchanged from a quarter earlier.
- SV Health Investors's biggest Q4 2020 reduction was American Well, cutting an estimated $8.3M.
- SV Health Investors fully exited Astria Therapeutics in Q4 2020, selling an estimated $1.77M.
- SV Health Investors's ten largest holdings make up 100% of its $208M portfolio in Q4 2020.
- SV Health Investors opened 0 new positions and closed 1 in Q4 2020.
- SV Health Investors's portfolio value rose 5.2% quarter-over-quarter to $208M.
Based on SV Health Investors's 13F filing for Q4 2020, filed 16 Feb 2021.